The influence of Aricept on stress and depression in caregivers
This study investigates the influence of Aricept (Donepezil Hydrochloride) on stress and depression in relatives (n=10) who identified themselves as the primary caregivers of a spouse or parent with Alzheimer's Disease. Measures wee administered to carers at baseline and 8-12 weeks after their...
| Main Author: | |
|---|---|
| Published: |
University of Edinburgh
2000
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.643255 |
| Summary: | This study investigates the influence of Aricept (Donepezil Hydrochloride) on stress and depression in relatives (n=10) who identified themselves as the primary caregivers of a spouse or parent with Alzheimer's Disease. Measures wee administered to carers at baseline and 8-12 weeks after their dependant's treatment with Aricept had commenced in order to assess improvement in levels of stress and depression. Data was also collected from matched sample (n=10) to compare levels of stress and depression in carers whose relative was not receiving Aricept. The relationship of patient and carer variables (rated by caregivers) to carer stress and depression was also investigated to see if these improve following pharmacological treatment for dementia. Outcome measures include the Relative's Stress Scale (RSS), the Beck Depression Inventory (BDI), the Behaviour and Mood Disturbance Scale (BMDS) and Gilleard <i>et al.</i>'s (1984) Problem Checklist. Quantitative and qualitative results are reported. Results are compared to previous findings and recommendations for future research are discussed. |
|---|